Sanofi (SNY) Stock Price, News & Analysis

Company Overview

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines. Notable products developed or marketed by Sanofi include Dupixent (dupilumab), an immunology biologic for conditions such as atopic dermatitis and asthma developed in collaboration with Regeneron, and long‑acting insulin products in diabetes care. Through Sanofi Pasteur, the company produces vaccines for infectious diseases and maintains global vaccine manufacturing and distribution capabilities. Sanofi’s portfolio also encompasses over‑the‑counter and consumer healthcare items alongside its prescription medicines.

The current Sanofi group is the result of decades of industry consolidation and strategic acquisitions that brought together French and international pharmaceutical operations into a single global company. Sanofi invests heavily in research and development, focusing on biologics, vaccines, gene and cell therapies, and targeted small molecules to address unmet medical needs. Paul Hudson has served as chief executive officer since 2019, leading the company’s strategic priorities in innovation, portfolio optimization and global commercial execution.

Key Stats

• Today's Range: $44.30 to $44.83
• 50-Day Range: $42.42 to $48.18
• 52-Week Range: $42.33 to $53.36
• Volume: 2.74 million shs
• Average Volume: 3.68 million shs
• Market Capitalization: $108.95 billion
• P/E Ratio: 12.48
• Dividend Yield: 3.96%
• Price Target: $51.00
• Consensus Rating: Hold

Sanofi Stock Analysis - MarketRank™

Sanofi scored higher than 83% of companies evaluated by MarketBeat, and ranked 80th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Hold

Consensus Rating

Sanofi has received a consensus rating of Hold. The company's average rating score is 2.47, and is based on 2 strong buy ratings, 3 buy ratings, 10 hold ratings, and no sell ratings.

Upside Potential

Sanofi has a consensus price target of $51.00, representing about 13.9% upside from its current price of $44.80.

Amount of Analyst Coverage

Sanofi has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.62%

Earnings Growth

Earnings for Sanofi are expected to grow by 4.62% in the coming year, from $4.98 to $5.21 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sanofi is 12.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.51.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sanofi is 12.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.71.

Price to Earnings Growth Ratio

Sanofi has a PEG Ratio of 1.07. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sanofi has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.33% of the float of Sanofi has been sold short.

Short Interest Ratio / Days to Cover

Sanofi has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sanofi has recently increased by 3.40%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Leadership

Sanofi is a leading dividend payer. It pays a dividend yield of 4.06%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sanofi does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sanofi is 49.44%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Sanofi will have a dividend payout ratio of 33.97% next year. This indicates that Sanofi will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 0.50

News Sentiment

Sanofi has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Sanofi this week, compared to 9 articles on an average week.

Search Interest

13 people have searched for SNY on MarketBeat in the last 30 days. This is an increase of 44% compared to the previous 30 days.

MarketBeat Follows

10 people have added Sanofi to their MarketBeat watchlist in the last 30 days. This is an increase of 43% compared to the previous 30 days.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sanofi insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.00% of the stock of Sanofi is held by insiders.

Percentage Held by Institutions

14.03% of the stock of Sanofi is held by institutions.

Company Calendar

• Last Earnings: 10/24/2025
• Record date for 6/3 Dividend: 5/04/2026
• Ex-Dividend for 6/3 Dividend: 5/04/2026
• Today: 5/20/2026
• Dividend Payable: 6/03/2026
• Next Earnings (Estimated): 7/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Large Cap Pharma
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SNY
• CIK: 1121404
• Web: www.sanofi.com
• Phone: (315) 377-4000
• Fax: 33-1-53-77-43-03
• Employees: 74,846
• Year Founded: 1994

Price Target and Rating

• Average Price Target for Sanofi: $51.00
• High Price Target: $52.00
• Low Price Target: $50.00
• Potential Upside/Downside: +14.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.47
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.58
• Trailing P/E Ratio: 12.48
• Forward P/E Ratio: 8.97
• P/E Growth: 1.07
• Net Income: $8.84 billion
• Net Margins: 16.95%
• Pretax Margin: 13.75%
• Return on Equity: 13.39%
• Return on Assets: 7.58%

Debt

• Debt-to-Equity Ratio: 0.17
• Current Ratio: 1.01
• Quick Ratio: 0.22

Sales & Book Value

• Annual Sales: $49.35 billion
• Price / Sales: 2.21
• Cash Flow: $7.25 per share
• Price / Cash Flow: 6.16
• Book Value: $35.10 per share
• Price / Book: 1.27

Miscellaneous

• Outstanding Shares: 2,439,000,000
• Free Float: 2,414,614,000
• Market Cap: $108.95 billion
• Optionable: Optionable
• Beta: 0.35